Search Results - David X. Overton
- Showing 1 - 2 results of 2
-
1
Cell-targeted PD-1 agonists are potent NK-cell inhibitors by Harriet C. Pope, Harriet C. Pope, Ana L. Chiodetti, Alice Newey, Guillaume Rieunier, David X. Overton, Eduardo Mateos-Diaz, Tara M. Mahon, Giovanna Bossi, Hussein Al-Mossawi, Charlotte Viant
Published in Frontiers in Immunology (2025-08-01)Get full text
Article -
2
Cell-targeted PD-1 agonists that mimic PD-L1 are potent T cell inhibitors by Adam P. Curnock, Giovanna Bossi, Jyothi Kumaran, Lindsay J. Bawden, Rita Figueiredo, Rajeevkumar Tawar, Katherine Wiseman, Emma Henderson, Sec Julie Hoong, Veronica Gonzalez, Hemza Ghadbane, David E.O. Knight, Ronan O’Dwyer, David X. Overton, Christina M. Lucato, Nicola M.G. Smith, Carlos R. Reis, Keith Page, Lorraine M. Whaley, Michelle L. McCully, Stephen Hearty, Tara M. Mahon, Peter Weber
Published in JCI Insight (2021-10-01)Get full text
Article
